ConforMIS expanded its Series E financing to $167.7 million, according to a News-Medical report.
Participants include government investment funds, private equity funds and sovereign wealth funds in the U.S. and abroad.
The orthopedic implant company plans to use the funds for developing and marketing its iTotal G2 total knee replacement system.
More Articles on Devices:
15 News Updates for Spine & Orthopedic Device Companies
Smith & Nephew Orthopedics Business Struggles in Q2
DiFusion Technologies Partners With Emergent Technologies for Spinal Implant